Its ability to penetrate the BBB, its metabolic stability, and its significant efficacy in restoring cognitive and motor functions in animal models of AD and PD, likely through modulating the HGF/c-Met system, position it as a highly promising therapeutic candidate for these debilitating neurodegenerative diseases [2]
Drug prescription data both prior to [22, 119, 120] and during [23] the Covid-19 pandemic has shown that many eligible patients do not receive SGLT2i or GLP-1 RA
Whereas GLP-1 decreases plasma glucose levels by exerting insulinotropic effects, glucagon stimulates hyperglycemia by enhancing hepatic glucose output
In our study, we observed a modest improvement or slight reduction in cardiac hypertrophy in MC4R KO mice treated with GLP-1 analogs, which further supports the notion that these drugs have potential cardiovascular benefits
Giao hng siu tc: Nhn hng ch sau 2 gi (Ni thnh TP.HCM)